Applicability of PD-L1 tests to tailor triple-negative breast cancer treatment in Brazil

• Main Authors: Kátia Ramos Moreira Leite (Author), Carlos Henrique Barrios (Author), Antônio Carlos Buzaid (Author), Débora Gagliato (Author), Helenice Gobbi (Author), Fernando Soares (Author)
• Format: Book
• Published: BMC, 2021-04-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Background Triple-negative breast cancer (TNBC) is a heterogeneous disease that represents 10-20% of breast cancer cases. The prognosis for advanced TNBC is usually poor, with a median overall survival of approximately 18 months or less. Main text New targeted therapies such as anti-PD-L1 a...